OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
30 hedge funds and large institutions have $7.42M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
30
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.14M | |
| 2 | +$973K | |
| 3 | +$220K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$122K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$93.2K |
Top Sellers
| 1 | -$3.65M | |
| 2 | -$1.15M | |
| 3 | -$124K | |
| 4 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$72.1K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$38K |